NF-κB Signaling | NF-kappaB Pathway
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions: Molecular Therapy - Nucleic Acids
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System | HTML
Regulation of DNA Repair Process by the Pro-Inflammatory NF-κB Pathway | IntechOpen
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
Targeting DNA repair pathway in cancer: Mechanisms and clinical application - Wang - 2021 - MedComm - Wiley Online Library
Schematic illustration of the pathways linking NF-κB to cellular... | Download Scientific Diagram
NF-kB: THE PATHWAY OF INFLAMMATION. Good cop, bad cop:... - IRM
The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System | Circulation Research
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
Role of NF-κB in the skeleton | Cell Research
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
The role of nuclear factor kappa B in human labour in: Reproduction Volume 130 Issue 5 (2005)
New insights into acquired endocrine resistance of breast cancer
DNA Damage Response and Metabolic Reprogramming in Health and Disease: Trends in Genetics
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways | Scientific Reports
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
